Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol. 2003;41:2280 7. 14. Pizarro R, Bazzino OO, Oberti PF, et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol. 2009;54:1099 106. 15. Alashi A, Mentias A, Patel K, et al. Synergistic utility of brain natriuretic peptide and left ventricular global longitudinal strain in asymptomatic patients with significant primary mitral regurgitation and preserved sys- tolic function undergoing mitral valve surgery. Circ Cardiovasc Imaging. 2016;9:e004451. 16. Klaar U, Gabriel H, Bergler-Klein J, et al. Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgi- tation. Eur J Heart Fail. 2011;13:163 9. 17. Mentias A, Patel K, Patel H, et al. Prognostic utility of brain natri- uretic peptide in asymptomatic patients with significant mitral regur- gitation and preserved left ventricular ejection fraction. Am J Cardiol. 2016;117:258 63. 18. Magne J, Mahjoub H, Pierard LA, et al. Prognostic importance of brain na- triuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart. 2012;98:584 91. 19. Hiemstra YL, Tomsic A, van Wijngaarden SE, et al. Prognostic value of global longitudinal strain and etiology after surgery for primary mitral re- gurgitation. JACC Cardiovasc Imaging. 2020;13:577 85. 20. Clavel M-A, Tribouilloy C, Vanoverschelde J-L, et al. Association of B-type natriuretic peptide with survival in patients with degenerative mitral regur- gitation. J Am Coll Cardiol. 2016;68:1297 307. 21. Kim HM, Cho G-Y, Hwang I-C, et al. Myocardial strain in prediction of outcomes after surgery for severe mitral regurgitation. JACC Cardiovasc Imaging. 2018;11:1235 44. 7.2.2.4. Diagnostic Testing: Cardiac Catheterization 1. Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation. 2012;125:2138 50. CLINICAL STATEMENTS AND GUIDELINES 7.2.2.5. 